Histology And Cytology Market Size Worth $37.7 Billion By 2028: Grand View Research, Inc.

The global histology and cytology market size is expected to reach USD 37.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.1% from 2021 to 2028. The factors contributing to market growth include increasing incidence of cancer, development of advanced tools for early disease diagnosis, implementation of immunohistochemistry, and innovation in microscopy.

Key suggestions from the report:

• The cytology segment accounted for the largest revenue share in 2020 and is expected to continue the trend in the forecast period owing to the integration of computational analytical tools for advancing cytology system
• The histology is expected to witness gradual growth from 2021 to 2028 owing to moderate innovation in histological systems
• The consumables and reagents segment dominated the market, attributed to the expanding portfolios of the entities operating in the consumable market space
• The instruments and analysis software system segment is expected to witness a substantial CAGR from 2021 to 2028, attributed to the steep increase in the demand for automated histology instruments
• The cervical cancer segment represented the majority of the market in 2020 owing to the increasing application of the Pap test in the early diagnosis of cervical cancer
• Institutes are integrating computer algorithm for improving the accuracy and efficiency of cervical cancer screening
• For instance, in June 2020, an NIH study integrated a computer algorithm with cytology (Pap test) for increasing the efficiency of cervical cancer screening. The new approach involves an AI platform for dual-stain evaluation
• The other cancers segment is expected to witness a lucrative growth rate of 18.0% owing to increasing diagnosis of various cancers such as pancreatic cancer and bladder cancer with histopathology and cytopathology
• The drug discovery and designing segment accounted for the highest revenue share in 2020 owing to the growing importance of cytopathology in disease understanding, further aimed at rapid drug development
• North America accounted for the highest revenue share in 2020, owing to the prevalence of cancer, presence of key players, and developed healthcare infrastructure

Read 150 page research report with ToC on “Histology And Cytology Market Size, Share & Trends Analysis Report By Type Of Examination (Histology, Cytology), By Product, By Application (Drug Discovery & Designing, Research), By Region, And Segment Forecasts, 2021 – 2028” at: https://www.grandviewresearch.com/industry-analysis/histology-and-cytology-market

In addition, organizations are collaborating for the standardization of cytopathology across the world, which is driving the market. For instance, in May 2020, International Agency for Research on Cancer (IARC) entered in collaboration with The International Academy of Cytology (IAC) for publishing a series of cytopathology reporting systems, for presenting an international approach that can be used for cytopathology of different body sites. The two organizations are engaged in the expansion and development of internationally recognized diagnostic reports for cancer and other precancerous disorders worldwide.

Moreover, companies are launching new and automated instruments for cytology which can be further attributed to the market growth. For instance, ELITechGroup Inc., in March 2020, launched Aerospray Cytology Slide Stainer Cytocentrifuge. It helps in the automation of the staining and preparation of specimens that are used in liquid-based cytology for facilitating the investigation of a collection of cell differentiation by using Papanicolaou staining techniques.

COVID-19 has become a catalyst for changing traditional pathology workflows with the integration of Artificial Intelligence (AI) and digitalization solutions. During the pandemic, these tools have helped and continue to assist in remote reviewing of pathological cases hence preventing delay in patient care. Companies have reported the increasing adoption of digital pathology solutions post COVID-19.

Grand View Research has segmented the global histology and cytology market based on examination, product, application, and region:

• Histology & Cytology Type Of Examination Outlook (Revenue, USD Million, 2017 – 2028)
  • Histology
    • By Technique
      • Microscopy
      • Immunohistochemistry
      • Molecular pathology
      • Cryostat & Microtomy
  • Cytology
    • By Technique
      • Microscopy
      • Immunohistochemistry
      • Molecular pathology
      • Cryostat & Microtomy
    • By Application
      • Breast Cancer
      • Cervical Cancer
      • Bladder Cancer
      • Lung Cancer
      • Other Cancer

• Histology & Cytology Product Outlook (Revenue, USD Million, 2017 – 2028)
  • Instruments and Analysis Software System
  • Consumable and Reagents

• Histology & Cytology Application Outlook (Revenue, USD Million, 2017 – 2028)
  • Drug Discovery & Designing
  • Clinical Diagnostics
  • Research
• Histology & Cytology Regional Outlook (Revenue, USD Million, 2017 – 2028)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

List of Key Players of Histology And Cytology Market

• Hologic, Inc.
• F. Hoffmann-La Roche Ltd.
• Abbott
• Becton, Dickinson and Company
• Danaher
• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Sysmex Corporation
• Trivitron Healthcare
• Koninklijke Philips N.V.

Find more research reports on  Clinical Diagnostics Industry, by Grand View Research:

• Immunohistochemistry Market– The global immunohistochemistry market size was valued at USD 1.8 billion in 2019 and is expected to witness lucrative growth at a CAGR of  7.8% over the forecast period.
• Hemato Oncology Testing Market– The global hemato oncology testing market size was estimated at USD 2.5 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 14.6% from 2020 to 2027.
• In-vitro Diagnostics Enzymes Market– The global in-vitro diagnostics enzymes market size was valued at USD 706.97 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 8.97% from 2020 to 2027.